278 papers found
Refreshing results…
T-24 Donor-related characteristics as predictors of sustained virologic response to antiviral therapy in recurrent hepatitis C after liver transplantation
F-39 Is the primary immunosuppressive drug playing a role on the response to antiviral treatment for post-transplant HCV recurrence?
T-44 Impact of antiviral therapy on fibrosis progression due to HCV recurrence after liver transplantation: Results from the AISF RECOLT-C study group
F-31 The persistence of HCV replication is associated with an increased mortality rate in HCV recurrent transplant patients: Results from the AISF-RECOLT-C group
F-10 Acute and chronic rejection during interferon therapy in HCV recurrent transplant patients: Results from the AISF-RECOLT-C group
OC-7 A SVR to post-LT antiviral treatment improves long-term survival in patients with genotype 1 HCV recurrence: An “AISF RECOLT-C” Group Study
OC-24 The best matching for HCV genotype 1 liver transplant recipients is predicted by HCV1-STAR. A study from “AISF RECOLT-C” database
T-23 Poor adherence to pegylated interferon and ribavirin is a major concern in the treatment of hepatitis C after liver transplantation: Evidence from the AISF RECOLT-C study group
T-43 Treatment of the “uncommon” HCV genotype 4 infection recurrence after liver transplantation. Data from AISF RECOLT-C group
Veicolo Ibrido Multimodale E Dispositivo Di Collegamento in Un Sistema Di Trazione Ibrida
Impact of Antiviral Therapy on Fibrosis Progression Due to HCV Recurrence after Liver Transplantation: Results from the AISF RECOLT-C Study Group
Road signs perception evaluation by means of a semi-immersive tool
Engineering designer curricula and creativity development
The Persistence of HCV Replication Is Associated with an Increased Mortality Rate in HCV Recurrent Transplant Patients: Results from the AISF-RECOLT-C Group
Acute and Chronic Rejection During Interferon Therapy In Hcv Recurrent Transplant Patients: Results Form the Aisf-recolt-c Group
Acute and Chronic Rejection During Interferon Therapy In Hcv Recurrent Liver Transplant Patients: Results From the Aisf-recolt-c Group
A computer tool to extract feasible assembly sequences from a product CAD model, in automated way
Proposal About the Use of Data Base in Engineering Design
Acute and Chronic Rejection during Interferon Therapy in HCV Recurrent Transplant Patients: Results from the AISF-RECOLT-C Group
PROTRACTED ANTIVIRAL TREATMENT BEYOND CONVENTIONAL TIME LIMITS IMPROVES SURVIVAL IN NON-RESPONDERS TO INTERFERON Plus RIBAVIRIN ADMINISTERED FOR HCV RECURRENCE AFTER LIVER TRANSPLANTATION
Missing publications? Read more about our data sources.